Cargando…
Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
BACKGROUND: Endocan is a soluble dermatan sulfate proteoglycan (50 kDa) secreted by endothelial cells and expressed by dermal, coronary, pulmonary and adipose tissue microvasculature. It plays an important role in the pathogenesis of vascular disorders, inflammatory state, endothelium dysfunction an...
Autores principales: | Morace, Carmela, Curatola, Selenia Lorenza, Mandraffino, Giuseppe, Scuruchi, Michele, Serrano’, Angela Elvira, Tropeano, Angelo, Lombardo, Fortunato, Salzano, Giuseppina, Squadrito, Giovanni, Versace, Antonio Giovanni, Valenzise, Mariella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468868/ https://www.ncbi.nlm.nih.gov/pubmed/37653524 http://dx.doi.org/10.1186/s13052-023-01510-y |
Ejemplares similares
-
Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension
por: Lo Gullo, Alberto, et al.
Publicado: (2021) -
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
por: Scicali, Roberto, et al.
Publicado: (2022) -
Clinical Peculiarities in a Cohort of Patients with Wolfram Syndrome 1
por: Salzano, Giuseppina, et al.
Publicado: (2022) -
Endocan Knockdown Down-Regulates the Expression of Angiogenesis-Associated Genes in Il-1ß Activated Chondrocytes
por: Scuruchi, Michele, et al.
Publicado: (2023) -
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy
por: Toscano, Arianna, et al.
Publicado: (2022)